Cargando…

Comparison of drug safety data obtained from the monitoring system, literature, and social media: An empirical proof from a Chinese patent medicine

OBJECTIVES: To investigate the consistency of adverse events (AEs) and adverse drug reactions (ADRs) reported in the literature, monitoring and social media data. METHODS: Using one Chinese patent medicine-Cordyceps sinensis extracts (CSE) as an example, we obtained safety data from the national mon...

Descripción completa

Detalles Bibliográficos
Autores principales: Hu, Ruixue, Golder, Su, Yang, Guoyan, Li, Xun, Wang, Di, Wang, Liqiong, Xia, Ruyu, Zhao, Nanqi, Fang, Sainan, Lai, Baoyong, Liu, Jianping, Fei, Yutong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6834258/
https://www.ncbi.nlm.nih.gov/pubmed/31693665
http://dx.doi.org/10.1371/journal.pone.0222077
_version_ 1783466454414262272
author Hu, Ruixue
Golder, Su
Yang, Guoyan
Li, Xun
Wang, Di
Wang, Liqiong
Xia, Ruyu
Zhao, Nanqi
Fang, Sainan
Lai, Baoyong
Liu, Jianping
Fei, Yutong
author_facet Hu, Ruixue
Golder, Su
Yang, Guoyan
Li, Xun
Wang, Di
Wang, Liqiong
Xia, Ruyu
Zhao, Nanqi
Fang, Sainan
Lai, Baoyong
Liu, Jianping
Fei, Yutong
author_sort Hu, Ruixue
collection PubMed
description OBJECTIVES: To investigate the consistency of adverse events (AEs) and adverse drug reactions (ADRs) reported in the literature, monitoring and social media data. METHODS: Using one Chinese patent medicine-Cordyceps sinensis extracts (CSE) as an example, we obtained safety data from the national monitoring system (July 2002 to February 2016), literature (up to November 2016) and social media (May 2019). For literature data, we searched the Chinese National Knowledge Infrastructure Database (CNKI), WanFang database, Chinese Science and Technology Periodical Database (VIP), Chinese Biomedical Literature Database (SinoMed), PubMed, Embase and the Cochrane Library. Social media data was from the Baidu post bar and Sina micro-blog. Two authors independently screened the literature and extracted data by PRISMA Harms checklist was followed. AEs and ADRs were coded using the World Health Organization Adverse Reaction Terminology (WHO-ART). AEs and ADRs were grouped into thirty-one organ-system classes for comparisons. Frequencies, relative frequencies and rank were used as metrics. Radar chart was used to manifest the features of the distributions and proportions. RESULTS: 610 AEs reported in CFDA monitoring data were associated with CSE, of which 537 (88.03%) were suspected ADRs (10.49% certain). 5568 AEs were identified from 172 papers (63% RCTs, 37% other types of studies including case series, case reports, ADR monitoring reports and reviews), in which 86 (1.54%) were ADRs (1.54% certain). 15 AEs (0 certain ADR) were identified from social media. AEs, ADRs and their affected system-organ classes, looked largely similar, but different in every aspect when looking at details. Data from RCTs demonstrated the most disparity. CONCLUSIONS: In our study, the most prevalent AEs and ADRs, mainly gastro-intestinal system disorders including nausea, diarrhea and vomiting, in monitoring system were largely similar with those in literature and social media. But data from different sources varied if looked at details. Multiple data sources (the monitoring system, literature and social media) should be integrated to collect safety information of interventions. The distributions of AEs and ADRs from RCTs were least similar with the data from other sources. Our empirical proof is consistent with other similar studies.
format Online
Article
Text
id pubmed-6834258
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-68342582019-11-14 Comparison of drug safety data obtained from the monitoring system, literature, and social media: An empirical proof from a Chinese patent medicine Hu, Ruixue Golder, Su Yang, Guoyan Li, Xun Wang, Di Wang, Liqiong Xia, Ruyu Zhao, Nanqi Fang, Sainan Lai, Baoyong Liu, Jianping Fei, Yutong PLoS One Research Article OBJECTIVES: To investigate the consistency of adverse events (AEs) and adverse drug reactions (ADRs) reported in the literature, monitoring and social media data. METHODS: Using one Chinese patent medicine-Cordyceps sinensis extracts (CSE) as an example, we obtained safety data from the national monitoring system (July 2002 to February 2016), literature (up to November 2016) and social media (May 2019). For literature data, we searched the Chinese National Knowledge Infrastructure Database (CNKI), WanFang database, Chinese Science and Technology Periodical Database (VIP), Chinese Biomedical Literature Database (SinoMed), PubMed, Embase and the Cochrane Library. Social media data was from the Baidu post bar and Sina micro-blog. Two authors independently screened the literature and extracted data by PRISMA Harms checklist was followed. AEs and ADRs were coded using the World Health Organization Adverse Reaction Terminology (WHO-ART). AEs and ADRs were grouped into thirty-one organ-system classes for comparisons. Frequencies, relative frequencies and rank were used as metrics. Radar chart was used to manifest the features of the distributions and proportions. RESULTS: 610 AEs reported in CFDA monitoring data were associated with CSE, of which 537 (88.03%) were suspected ADRs (10.49% certain). 5568 AEs were identified from 172 papers (63% RCTs, 37% other types of studies including case series, case reports, ADR monitoring reports and reviews), in which 86 (1.54%) were ADRs (1.54% certain). 15 AEs (0 certain ADR) were identified from social media. AEs, ADRs and their affected system-organ classes, looked largely similar, but different in every aspect when looking at details. Data from RCTs demonstrated the most disparity. CONCLUSIONS: In our study, the most prevalent AEs and ADRs, mainly gastro-intestinal system disorders including nausea, diarrhea and vomiting, in monitoring system were largely similar with those in literature and social media. But data from different sources varied if looked at details. Multiple data sources (the monitoring system, literature and social media) should be integrated to collect safety information of interventions. The distributions of AEs and ADRs from RCTs were least similar with the data from other sources. Our empirical proof is consistent with other similar studies. Public Library of Science 2019-11-06 /pmc/articles/PMC6834258/ /pubmed/31693665 http://dx.doi.org/10.1371/journal.pone.0222077 Text en © 2019 Hu et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Article
Hu, Ruixue
Golder, Su
Yang, Guoyan
Li, Xun
Wang, Di
Wang, Liqiong
Xia, Ruyu
Zhao, Nanqi
Fang, Sainan
Lai, Baoyong
Liu, Jianping
Fei, Yutong
Comparison of drug safety data obtained from the monitoring system, literature, and social media: An empirical proof from a Chinese patent medicine
title Comparison of drug safety data obtained from the monitoring system, literature, and social media: An empirical proof from a Chinese patent medicine
title_full Comparison of drug safety data obtained from the monitoring system, literature, and social media: An empirical proof from a Chinese patent medicine
title_fullStr Comparison of drug safety data obtained from the monitoring system, literature, and social media: An empirical proof from a Chinese patent medicine
title_full_unstemmed Comparison of drug safety data obtained from the monitoring system, literature, and social media: An empirical proof from a Chinese patent medicine
title_short Comparison of drug safety data obtained from the monitoring system, literature, and social media: An empirical proof from a Chinese patent medicine
title_sort comparison of drug safety data obtained from the monitoring system, literature, and social media: an empirical proof from a chinese patent medicine
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6834258/
https://www.ncbi.nlm.nih.gov/pubmed/31693665
http://dx.doi.org/10.1371/journal.pone.0222077
work_keys_str_mv AT huruixue comparisonofdrugsafetydataobtainedfromthemonitoringsystemliteratureandsocialmediaanempiricalprooffromachinesepatentmedicine
AT goldersu comparisonofdrugsafetydataobtainedfromthemonitoringsystemliteratureandsocialmediaanempiricalprooffromachinesepatentmedicine
AT yangguoyan comparisonofdrugsafetydataobtainedfromthemonitoringsystemliteratureandsocialmediaanempiricalprooffromachinesepatentmedicine
AT lixun comparisonofdrugsafetydataobtainedfromthemonitoringsystemliteratureandsocialmediaanempiricalprooffromachinesepatentmedicine
AT wangdi comparisonofdrugsafetydataobtainedfromthemonitoringsystemliteratureandsocialmediaanempiricalprooffromachinesepatentmedicine
AT wangliqiong comparisonofdrugsafetydataobtainedfromthemonitoringsystemliteratureandsocialmediaanempiricalprooffromachinesepatentmedicine
AT xiaruyu comparisonofdrugsafetydataobtainedfromthemonitoringsystemliteratureandsocialmediaanempiricalprooffromachinesepatentmedicine
AT zhaonanqi comparisonofdrugsafetydataobtainedfromthemonitoringsystemliteratureandsocialmediaanempiricalprooffromachinesepatentmedicine
AT fangsainan comparisonofdrugsafetydataobtainedfromthemonitoringsystemliteratureandsocialmediaanempiricalprooffromachinesepatentmedicine
AT laibaoyong comparisonofdrugsafetydataobtainedfromthemonitoringsystemliteratureandsocialmediaanempiricalprooffromachinesepatentmedicine
AT liujianping comparisonofdrugsafetydataobtainedfromthemonitoringsystemliteratureandsocialmediaanempiricalprooffromachinesepatentmedicine
AT feiyutong comparisonofdrugsafetydataobtainedfromthemonitoringsystemliteratureandsocialmediaanempiricalprooffromachinesepatentmedicine